This site is intended for Healthcare Professionals only

Voltarol’s Global Pain Index survey returns

Latest bookmark icon off

Voltarol’s Global Pain Index survey returns

GSK’s topical pain relief brand Voltarol is continuing to explore the impact of pain with its latest global consumer survey into attitudes towards body pain. The study revealed that while 95 per cent of people in the UK have experienced body pain, knowledge about pain medications varies: 51 per cent felt very knowledgeable about dosing, while around three in 10 said the same about potential risks (28 per cent) and side effects (30 per cent). GSK says these findings indicate an important opportunity for pharmacy teams to educate customers in the pain category. 

The Global Pain Index study, first launched in 2016, has been extended to cover 32 countries and includes both body and head pain. 

GlaxoSmithKline: 0800 783 8881

 

Copy Link copy link button

Latest

Share: